Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Osteoporosis in Men on ADT for Prostate Cancer
NCT00171639Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zoledronic acid, sponsored by Novartis. Started Jun 2004; status: completed.
02
Drugs
zoledronic acid
Beyond the preview
Go deeper on NCT00171639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171639.